Cargando…
Current treatment options for craniofacial hyperhidrosis
Hyperhidrosis (HH) is characterized by sweating exceeding the amount necessary to meet the thermal regulation and physiological needs of the body. Approximately 9.41% of individuals with HH have craniofacial hyperhidrosis (FH). The present study aims to review the most current data in the literature...
Autores principales: | Wolosker, Nelson, Faustino, Carolina Brito, da Silva, Marcelo Fiorelli Alexandrino, de Campos, José Ribas Milanez, Kauffman, Paulo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218019/ https://www.ncbi.nlm.nih.gov/pubmed/34211510 http://dx.doi.org/10.1590/1677-5449.200152 |
Ejemplares similares
-
Cohort study on 20 years’ experience of bilateral video-assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients
por: Wolosker, Nelson, et al.
Publicado: (2022) -
Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin
por: Kamikava, Débora Yumi Ferreira, et al.
Publicado: (2021) -
Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin
por: Teivelis, Marcelo Passos, et al.
Publicado: (2014) -
Objective evaluation of plantar hyperhidrosis after sympathectomy
por: Wolosker, Nelson, et al.
Publicado: (2013) -
Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years
por: Wolosker, Nelson, et al.
Publicado: (2014)